Marlys L. Koschinsky, PhD, is the new Scientific and Executive Director for Western University’s Robarts Research Institute.
Established in 1986, Robarts Research Institute at the Schulich School of Medicine & Dentistry is a world leader in biomedical knowledge – at the forefront of innovating, educating and translating research discoveries into clinical applications for patients across the globe.
As a leading contributor to internationally renowned research, Robarts houses the only ultra-high field MRI machine in Canada, fosters key scientific breakthroughs, such as the use of aspirin to prevent stroke, and its core facilities, from imaging to genomics, support research in London and around the world.
Currently Dean of the Faculty of Science at the University of Windsor, Koschinsky brings an extensive research career with her to Robarts.
Koschinsky received her PhD in Biochemistry from the University of British Columbia in 1988 before completing a Medical Research Council of Canada postdoctoral fellowship at Genentech Inc., a biotechnology company in South San Francisco, in 1991.
She spent the next 17 years at Queen’s University, serving as the Director of the Cardiac, Circulatory & Respiratory Research Program and Acting Head of the Department of Physiology. In 2008, she accepted the position as Dean of the Faculty of Science at the University of Windsor.
Koschinsky’s research is in the areas of atherosclerosis and thrombosis, focusing on the understanding of mechanisms of risk factors for cardiovascular disease. She is an internationally recognized expert in the study of lipoprotein(a) – a genetic risk factor for cardiovascular disease – and is a well-respected opinion leader in the area of lipoproteins and cardiovascular disease.
With a strong commitment to community engagement, Koschinsky is involved with a number of organizations in Windsor. She is the Vice-Chair of the Board of Directors for WEtech Alliance, a senior leadership volunteer with the Heart and Stroke Foundation, Chair of the Windsor-Essex Mission Committee, and has served as a member of the Windsor-Essex Economic Development Corporation’s Life and Health Sciences Task Force. She is also a member of the steering committee for the South West Academic Health Network.
“It is a tremendous pleasure to welcome Marlys to the Schulich School of Medicine & Dentistry as the Scientific and Executive Director of the Robarts Research Institute,” said Dr. Michael Strong, dean, Schulich Medicine & Dentistry. “She brings to the Institute a highly respected and successful research career, proven leadership skills, and a thorough understanding of the Canadian research milieu. I am very much looking forward to her joining our leadership team.”
In her role as Scientific and Executive Director of the Robarts Research Institute, Koschinsky will provide strategic leadership to world-class, innovative scientists.
MEDIA CONTACT: Tristan Joseph, Media Relations Officer, Schulich School of Medicine & Dentistry, Western University, t. 519.661.2111 ext. 80387, c. 519.777.1573, email@example.com
Western delivers an academic experience second to none. Since 1878, The Western Experience has combined academic excellence with life-long opportunities for intellectual, social and cultural growth in order to better serve our communities. Our research excellence expands knowledge and drives discovery with real-world application. Western attracts individuals with a broad worldview, seeking to study, influence and lead in the international community.
ABOUT THE SCHULICH SCHOOL OF MEDICINE & DENTISTRY
The Schulich School of Medicine & Dentistry at Western University is one of Canada’s preeminent medical and dental schools. Established in 1881, it was one of the founding schools of Western University and is known for being the birthplace of family medicine in Canada. For more than 130 years, the School has demonstrated a commitment to academic excellence and a passion for scientific discovery.
Follow Western Media Relations online: